TRNS
Get informed when a big investor buys or sells
+ FollowUndervalued by 6% based on the discounted cash flow analysis.
| Market cap | $867.56 Million |
|---|---|
| Enterprise Value | $991.51 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.58 |
| Beta | 0.7 |
| Outstanding Shares | 9,345,000 |
| P/E Ratio | 149.52 |
|---|---|
| PEG | -179.42 |
| Price to Sales | 2.56 |
| Price to Book Ratio | 2.8 |
| Enterprise Value to Revenue | 2.99 |
| Enterprise Value to EBIT | 85.83 |
| Enterprise Value to Net Income | 237 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | 0.43 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 26.74% |
|---|---|
| Total Calls | 117,600▲ 528.88% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 103.20%▲ 6.41% |
|---|---|
| Total Invested | $681.90M▲ 37.88% |
| Investors Holding | 162▲ 10.00% |
No data
Transcat, Inc. is a leading provider of accredited calibration, repair, inspection and laboratory instrument services. The Company is focused on providing best-in-class services and products to highly regulated industries, particularly t...